Stock listing
Sangamo Therapeutics, Inc.
Selected listing: GBY · BX · CHF · CH
Sangamo Therapeutics, Inc. (BX Swiss: GBY). Latest release Jun 8, 2026: Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value…
- Ticker
- BX Swiss: GBY
- Asset type
- Stock
- Exchange
- BX Swiss
- Currency
- CHF
About Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (SGMO) is a public biotechnology company based in the United States, focused on developing innovative gene therapies for genetic diseases and other serious conditions. The company utilizes its proprietary technology platform to create targeted treatments aimed at addressing unmet medical needs. Sangamo is committed to advancing its research and development programs to improve patient outcomes.
Latest news from Sangamo Therapeutics, Inc.
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
June 8, 2026
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 14, 2026
Sangamo Therapeutics Announces First Quarter 2026 Earnings Call
May 10, 2026
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
April 30, 2026
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
April 29, 2026
Events
Research Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. company profile
View the public company page for Sangamo Therapeutics, Inc. on 6ix.
Sangamo Therapeutics, Inc. news
Read company news and market updates connected to Sangamo Therapeutics, Inc..
Sangamo Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sangamo Therapeutics, Inc..
Alternate listings
SGMO:NASDAQ
US · USD
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
SGMO:BOATS
US · USD
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
0R1D:LSE
GB · USD
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
936386:LSX
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:TRADEGATE
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:GETTEX
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
936386:LS
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:HAM
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:DUS
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:FWB
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:MUN
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.
GBY:SWB
DE · EUR
Alternate listing for Sangamo Therapeutics, Inc.; the primary context on this page is GBY:BX.